CD19-CART in the Treatment of R/R CD19 Positive Non-Hodgkin's Lymphoma

Condition:   Non Hodgkin Lymphoma Intervention:   Biological: CD19 CAR-T cells infusion Sponsors:   PersonGen BioTherapeutics (Suzhou) Co., Ltd.;   The First Affiliated Hospital of Zhengzhou University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials